Are all Y21 Xanax bars fake? (3+ features to check)
By
Dr Milena Locci de Oliveira (PhD)
Author bio
Dr Milena Locci de Oliveira is a Pharmacist and Doctor of Philosophy in Sciences from the University of São Paulo (USP). She has experience in microbiology, analytical toxicology, and clinical pharmacokinetics. She writes and reviews content on these topics.
Dr Milena’s Highlights:
-PhD in Sciences, University of São Paulo, Brazil, 2019.
-University College London (UCL) – Semester of remote collaboration in the areas of Pharmacometrics and Population Pharmacokinetics, 2018.
-Bachelor in Biochemical Pharmacy, University of São Paulo, Brazil, 2013.
“Science can be translated, and it is essential that everyone has access to quality information to make informed decisions” – Dr Milena Oliveira, PhD.
Professional Experience:
With a decade-long career as a researcher, Dr Milena has amassed extensive experience in conducting research projects in microbiology, analytical toxicology, and clinical pharmacokinetics.
Her expertise also extends to the preparation of technical and scientific reports, literature reviews, data analysis, and scientific communication, both oral and written.
Dr Milena has served as a Clinical Pharmacist, providing expert supervision and guidance to teams during the challenging times of the COVID-19 pandemic, particularly in the ICUs of two reference hospitals for patient hospitalization.
In her most recent role, Dr Milena worked on the implementation of the deliberatives of the São Paulo State Government Pharmaceutical Assistance Coordination. These decisions were aimed at ensuring medication access within the Unified Health System.
A widely multidisciplinary background enabled Dr Milena to become a professional capable of integrating scientific knowledge into private initiatives, education, and healthcare, delivering consistent services in patient safety and population health.
Professional Memberships & Affiliations:
Dr Milena Oliveira is a member of the Regional Council of Pharmacy of the State of São Paulo, Brazil.
Education:
-PhD in Sciences, University of São Paulo, Brazil, 2019.
-University College London (UCL) – Semester of remote collaboration, 2018.
-Bachelor in Biochemical Pharmacy, University of São Paulo, Brazil, 2013.
Relevant Published Work & Citations:
Oliveira ML de, Rocha A, Nardotto GHB, Pippa LF, Simões BP, Lanchote VL. Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia. Journal of Pharmaceutical and Biomedical Analysis. Nov 2020. 191:113-124.
Abstracts. CPT: Pharmacometrics & Systems Pharmacology. 2020 Nov; 9 (S1).
Pippa LF, Oliveira ML de, Rocha A, de Andrade JM, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: Estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis. 2020 Jun 5; 185:113-231.
Godoy ALPC, De Jesus C, De Oliveira ML, Rocha A, Pereira MPM, Larangeira DF, Lanchote VL, Barrouin-Melo SM. Determination of Allopurinol and Oxypurinol in Dogs Plasma by High-Performance Liquid Chromatography with an Ultraviolet Detector: Application for Pharmacokinetic Studies. J Chromatogr Sep Tech. 2017; 8 (4).
Clímaco EC, Oliveira ML de, Pitondo-Silva A, Oliveira MG, Medeiros M, Lincopan N, et al. Clonal complexes 104, 109 and 113 playing a major role in the dissemination of OXA-carbapenemase-producing Acinetobacter baumannii in Southeast Brazil. Infection, Genetics and Evolution. 2013 Oct;19:127–33.
Conference Papers:
Oliveira, M. L.; NARDOTTO, G. H. B.; PIPPA, L. F.; ROCHA, A.; SIMOES, B. P.; LANCHOTE, V. L. . Daunorubicin metabolism and urinary excretion in patients with acute myeloid leukemia. In: 84th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 20th Annual Meeting of the Association of the Clinical Pharmacology Germany (VKliPha), 2018, Göttingen. Naunyn-Schmiedeberg’s Arch Pharmacol, 2018. v. 391. p. S76-S76.
Oliveira, M. L.; NARDOTTO, G. H. B. ; ROCHA, A. ; SIMOES, B. P. ; LANCHOTE, V. L. . The low contribution of urinary excretion in the elimination of daunorubicin and its metabolite daunorubicinol in patients with acute myeloid leukemia. In: 49th Brazilian Congress of Pharmacology and Experimental Therapeutics., 2017, Ribeirão Preto. Livro de Resumos, 2017. p. 64-64.
Oliveira, M. L.; PIPPA, L. F. ; ROCHA, A. ; SIMOES, B. P. ; LANCHOTE, V. L. . Quantification of daunorubicin and its metabolite daunorubicinol in human plasma by LC-MS/MS. In: I International Meeting of Environmental Health and Toxicology (IMEHTOX), 2016, Ribeirão Preto. Livro de Resumos, 2016.
Oliveira, M. L.; Clímaco, E.C. ; OLIVEIRA, M. G. ; Lincopan, N. ; Darini A.L.C. . PFGE typing of Carbapenem-Resistant Acinetobacter baumannii isolated from different University Hospitals. In: V International Postgraduate and Research Symposium, 2012.
Clímaco, E.C. ; SILVA, A. P. ; Oliveira, M. L. ; OLIVEIRA, M. G. ; Lincopan, N. ; Darini A.L.C. Relação clonal entre linhagens de Acinetobacter baumannii produtoras de carbapenemases da família OXA em quatro hospitais no Brasil. In: XXI Latin American Congress of Microbiology, 2012, Santos. XXI Latin American Congress of Microbiology, 2012.
Oliveira, M. L.; Clímaco, E.C. ; OLIVEIRA, M. G. ; Darini A.L.C. . Dissemintion of OXA carbapenemases genes in carbapenem-resistant Acinetobacter baumannii in University Hospital of Juiz de Fora, MG. In: 8th CIFARP – International Congress of Pharmaceutical Sciences, 2011, Ribeirão Preto.
Clímaco, E.C. ; Oliveira, M. L. ; OLIVEIRA, M. G. ; Darini A.L.C. . Avaliação do sequenciamento parcial do gene rpoB e de seus flanqueadores para identificação de espécies de Acinetobacter na rotina laroratorial. In: 2° International Symposium on Clinical Microbiology, 2010, Florianópolis.
You can view some of Dr Milena’s work below and links to her professional profile.
Linkedin: https://www.linkedin.com/in/dra-milena-locci-de-oliveira-28986042/?locale=en_US
ResearchGate: https://www.researchgate.net/profile/Milena-Oliveira-6
Escavador: https://www.escavador.com/sobre/5394254/milena-locci-de-oliveira
Lattes: https://buscatextual.cnpq.br/buscatextual/busca.do
Scopus: https://www.scopus.com/authid/detail.uri?authorId=57199779361
Scholar: https://scholar.google.com/citations?view_op=list_works&hl=pt-BR&user=1YUBDIQAAAAJ
The purpose of this article is to answer the question, “Are all Y21 Xanax bars fake?” We will investigate the factors that contribute to the production of counterfeit Xanax bars and offer advice on how to tell the difference between genuine and counterfeit Xanax
Are all Y21 Xanax bars fake?
No, not all Y21 Xanax bars are fake. Especially when purchased from a reputable pharmacy, you can trust their authenticity.
Y21 Xanax is a brand of Alprazolam 2 mg supplied by Aurobindo Pharma Limited. Alprazolam, commonly known as Xanax, is a short-acting tranquillizer used for managing anxiety disorders, particularly panic disorder and generalized anxiety disorder.
Y21 Xanax is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA). Due to its addiction potential, there are many counterfeit Y21 Xanax bars on the black market.
To identify genuine Y21 Xanax, consider these characteristics: (1)
- The pill should be white.
- It should be rectangular.
- It should have the imprint Y 2 1 on one side.
- It should have a smooth surface and be free of any cracks or chips.
- The “Xanax” logo on the bar should be 3 dimensional
Taking real Y21 Xanax should result in a sense of calm, relaxation, and composure. These effects indicate that Xanax is effectively alleviating anxiety symptoms. It’s important to ensure you are using authentic medication for your safety and well-being.
Counterfeit Xanax can be extremely hazardous to health and even fatal. Therefore, exercise utmost caution when buying Xanax. Your health and safety should be a top priority.
How to identify a fake Y21 Xanax bar?
To identify a fake Y21 Xanax, you need to pay attention to various factors, as counterfeit pills can vary in appearance and characteristics. Here’s what to look for:
Different markings on the Xanax bar
Authentic Xanax bars bear a unique three-dimensional “XANAX” logo and Y21 on one side. When you flip the pill over, ensure that the letters appear to have depth, creating a 3D effect.
Counterfeit Xanax pills may have a flat or poorly defined logo, lacking this three-dimensional quality.
Additionally, a distinguishing characteristic of genuine Xanax is that if you open the pill, you should be able to see markings from the other side inside the pill. This feature is often absent in counterfeit pills.
Variation in colour
Authentic Xanax, typically prescribed in the United States, is known for its consistent appearance. It usually comes in two common colours: white or peach.
This colour exhibits a slightly opaque quality, resembling the colour of the pill itself. Authentic Xanax maintains this colour consistency throughout the entire batch.
However, when identifying fake Xanax bars, one of the critical factors to consider is any notable variation in colour.
If you notice Xanax pills that significantly differ in colour, such as being noticeably darker or lighter than the typical prescription pills you’ve encountered, it raises suspicion of them being counterfeit.
No uniform shape and texture
Genuine Xanax bars are distinctive in their appearance. They feature a rectangular shape with precisely defined, smooth edges.
The surface of authentic Xanax bars is notably smooth to the touch, without any roughness or chalky texture.
Any deviation from the rectangular shape or the presence of a rough, chalky texture can be indicative of counterfeit medication.
Different taste and solubility in water
One way to assess the authenticity of Xanax is by considering its taste and dissolvability. Genuine Xanax bars typically have a slightly bitter taste, which can be a noteworthy indicator of their genuineness.
To further confirm authenticity, you can perform a simple dissolvability test. Real Xanax should rapidly dissolve when placed in water, leaving no significant residue behind.
Conversely, if you encounter a Xanax pill that tastes sweet or has no taste at all, this deviation from the expected bitter taste may raise suspicion of counterfeiting. If the pill does not dissolve as expected when placed in water, it is another sign that it may be counterfeit.
What does fake Y21 Xanax contain?
Fake Y21 Xanax bars can contain various dangerous substances, posing significant risks to those who unwittingly consume them.
These counterfeits may consist of incorrect ingredients, have inaccurate dosages, or even include highly dangerous substances like fentanyl.
Fentanyl can be many times more potent than anticipated and overdosing on it can lead to death. (2)
In some cases, counterfeit Xanax bars may contain other drugs designed to mimic the sedative effects of authentic Xanax, such as SSRIs, benzodiazepines or mirtazapine.
What makes the situation even more challenging is that these counterfeit pills can closely resemble the genuine Xanax bar, making them difficult to distinguish based on appearance alone.
Conclusion
In conclusion, I want to emphasize that not all Y21 Xanax bars are fake. However, it’s essential to be cautious when buying them. Your health is vital, so make informed choices and purchase from reliable sources, like licensed pharmacies. If you have any doubts, consult with a healthcare provider or pharmacist.
